DENTIS CO.,Ltd (KOSDAQ:261200)
2,800.00
-45.00 (-1.58%)
At close: Jun 4, 2026
DENTIS CO.,Ltd Revenue
DENTIS CO.,Ltd had revenue of 30.19B KRW in the quarter ending March 31, 2026, a decrease of -7.04%. This brings the company's revenue in the last twelve months to 111.96B, down -5.28% year-over-year. In the year 2025, DENTIS CO.,Ltd had annual revenue of 114.25B, down -0.03%.
Revenue (ttm)
111.96B
Revenue Growth
-5.28%
P/S Ratio
0.38
Revenue / Employee
319.88M
Employees
390
Market Cap
42.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 114.25B | -38.13M | -0.03% |
| Dec 31, 2024 | 114.28B | 19.95B | 21.15% |
| Dec 31, 2023 | 94.33B | 7.25B | 8.32% |
| Dec 31, 2022 | 87.09B | 21.35B | 32.47% |
| Dec 31, 2021 | 65.74B | 19.02B | 40.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synergy Innovation | 112.84B |
| Corentec | 102.38B |
| M.I.TECH Co.,Ltd | 66.63B |
| BIOBIJOU | 24.92B |
| Alpha AI | 15.79B |
| Sanigen Co. | 14.45B |
| Finemedix | 9.86B |
| Genolution | 9.82B |